Concepts (292)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biosensing Techniques | 8 | 2022 | 130 | 2.540 |
Why?
|
| Surface Plasmon Resonance | 6 | 2021 | 35 | 2.010 |
Why?
|
| Nucleic Acid Amplification Techniques | 6 | 2022 | 40 | 1.900 |
Why?
|
| Colorimetry | 4 | 2016 | 52 | 1.050 |
Why?
|
| Models, Statistical | 2 | 2021 | 190 | 0.970 |
Why?
|
| DNA | 4 | 2021 | 594 | 0.960 |
Why?
|
| Metal Nanoparticles | 3 | 2016 | 227 | 0.860 |
Why?
|
| Clubfoot | 1 | 2023 | 2 | 0.850 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2025 | 358 | 0.830 |
Why?
|
| Gold | 4 | 2021 | 153 | 0.800 |
Why?
|
| Proteins | 2 | 2016 | 383 | 0.790 |
Why?
|
| Tomography | 1 | 2021 | 9 | 0.730 |
Why?
|
| Nucleic Acids | 1 | 2022 | 26 | 0.730 |
Why?
|
| Aptamers, Nucleotide | 3 | 2021 | 51 | 0.690 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2021 | 71 | 0.690 |
Why?
|
| Heart Arrest | 3 | 2015 | 52 | 0.660 |
Why?
|
| Cross-Over Studies | 2 | 2021 | 112 | 0.630 |
Why?
|
| DNA, Complementary | 2 | 2020 | 195 | 0.600 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 81 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 86 | 0.580 |
Why?
|
| Electrocardiography | 3 | 2015 | 184 | 0.530 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2016 | 3 | 0.520 |
Why?
|
| Urinalysis | 1 | 2017 | 34 | 0.520 |
Why?
|
| Kidney Tubules | 1 | 2017 | 38 | 0.510 |
Why?
|
| Optical Fibers | 1 | 2016 | 8 | 0.500 |
Why?
|
| Erythrocytes | 1 | 2017 | 126 | 0.490 |
Why?
|
| Influenza A virus | 1 | 2016 | 31 | 0.490 |
Why?
|
| Limit of Detection | 4 | 2021 | 82 | 0.480 |
Why?
|
| Mass Screening | 1 | 2020 | 531 | 0.480 |
Why?
|
| Hepacivirus | 1 | 2015 | 73 | 0.440 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 37 | 0.440 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 59 | 0.430 |
Why?
|
| Treatment Outcome | 7 | 2023 | 1586 | 0.420 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 182 | 0.420 |
Why?
|
| Epithelial Cells | 1 | 2017 | 426 | 0.410 |
Why?
|
| Odds Ratio | 1 | 2015 | 587 | 0.400 |
Why?
|
| Humans | 35 | 2025 | 42163 | 0.400 |
Why?
|
| Polycarboxylate Cement | 1 | 2011 | 1 | 0.370 |
Why?
|
| Hepatitis B virus | 1 | 2011 | 18 | 0.370 |
Why?
|
| Stomach Neoplasms | 2 | 2023 | 228 | 0.330 |
Why?
|
| DNA, Viral | 1 | 2011 | 323 | 0.320 |
Why?
|
| Ultrasonography, Doppler | 1 | 2009 | 8 | 0.300 |
Why?
|
| Image Enhancement | 1 | 2009 | 38 | 0.300 |
Why?
|
| Contrast Sensitivity | 1 | 2009 | 35 | 0.300 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 518 | 0.250 |
Why?
|
| Telemetry | 2 | 2015 | 13 | 0.230 |
Why?
|
| Burns | 1 | 2005 | 10 | 0.230 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 126 | 0.220 |
Why?
|
| Anti-Retroviral Agents | 1 | 2025 | 158 | 0.220 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2024 | 5 | 0.220 |
Why?
|
| Wound Healing | 1 | 2005 | 82 | 0.220 |
Why?
|
| Tendon Transfer | 1 | 2023 | 2 | 0.210 |
Why?
|
| Casts, Surgical | 1 | 2023 | 3 | 0.210 |
Why?
|
| Humeral Fractures | 1 | 2023 | 2 | 0.210 |
Why?
|
| Female | 16 | 2025 | 24018 | 0.210 |
Why?
|
| Nanostructures | 1 | 2006 | 158 | 0.210 |
Why?
|
| Heart Rate | 2 | 2015 | 261 | 0.210 |
Why?
|
| Medication Adherence | 1 | 2025 | 177 | 0.210 |
Why?
|
| Radius Fractures | 1 | 2023 | 4 | 0.200 |
Why?
|
| Retrospective Studies | 7 | 2023 | 2485 | 0.200 |
Why?
|
| HIV Infections | 3 | 2025 | 2535 | 0.200 |
Why?
|
| Databases, Factual | 1 | 2024 | 336 | 0.190 |
Why?
|
| Bone Nails | 3 | 2023 | 6 | 0.190 |
Why?
|
| Alcohol Drinking | 2 | 2025 | 585 | 0.190 |
Why?
|
| Fracture Fixation, Internal | 3 | 2023 | 11 | 0.190 |
Why?
|
| Helicobacter Infections | 1 | 2022 | 84 | 0.190 |
Why?
|
| Alcoholism | 1 | 2025 | 292 | 0.180 |
Why?
|
| Textiles | 1 | 2021 | 7 | 0.180 |
Why?
|
| Electric Impedance | 1 | 2021 | 28 | 0.180 |
Why?
|
| Helicobacter pylori | 1 | 2022 | 116 | 0.180 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2022 | 57 | 0.180 |
Why?
|
| Electrodes | 1 | 2021 | 57 | 0.180 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 66 | 0.180 |
Why?
|
| DNA Primers | 1 | 2022 | 295 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 2 | 2020 | 454 | 0.180 |
Why?
|
| Middle Aged | 11 | 2025 | 11819 | 0.170 |
Why?
|
| Ribonuclease P | 1 | 2020 | 2 | 0.170 |
Why?
|
| Ventricular Fibrillation | 2 | 2014 | 9 | 0.160 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 602 | 0.160 |
Why?
|
| Child | 6 | 2024 | 3381 | 0.160 |
Why?
|
| Microbial Viability | 2 | 2016 | 42 | 0.160 |
Why?
|
| Male | 15 | 2025 | 22779 | 0.160 |
Why?
|
| Certification | 1 | 2020 | 21 | 0.160 |
Why?
|
| Health Promotion | 1 | 2025 | 691 | 0.150 |
Why?
|
| Voice Disorders | 1 | 2018 | 1 | 0.150 |
Why?
|
| Adult | 12 | 2025 | 13458 | 0.150 |
Why?
|
| Adolescent | 8 | 2025 | 5950 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2020 | 404 | 0.140 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 1554 | 0.140 |
Why?
|
| Bone Screws | 2 | 2023 | 7 | 0.140 |
Why?
|
| Refractometry | 2 | 2021 | 16 | 0.130 |
Why?
|
| Animals | 8 | 2017 | 16695 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2017 | 1737 | 0.130 |
Why?
|
| Centrifugation | 1 | 2017 | 6 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 242 | 0.130 |
Why?
|
| Equipment Design | 2 | 2021 | 143 | 0.130 |
Why?
|
| Acetic Acid | 1 | 2016 | 19 | 0.130 |
Why?
|
| Escherichia coli O157 | 1 | 2016 | 17 | 0.130 |
Why?
|
| Cryopreservation | 1 | 2016 | 33 | 0.130 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 475 | 0.130 |
Why?
|
| Neuralgia | 1 | 2017 | 21 | 0.130 |
Why?
|
| Bacterial Toxins | 1 | 2016 | 50 | 0.130 |
Why?
|
| Aged | 7 | 2018 | 7982 | 0.120 |
Why?
|
| Heart Conduction System | 2 | 2014 | 15 | 0.120 |
Why?
|
| Influenza in Birds | 1 | 2016 | 11 | 0.120 |
Why?
|
| Algorithms | 3 | 2021 | 508 | 0.120 |
Why?
|
| Antigens, Viral | 1 | 2016 | 50 | 0.120 |
Why?
|
| Urethra | 1 | 2015 | 3 | 0.120 |
Why?
|
| Urination Disorders | 1 | 2015 | 4 | 0.120 |
Why?
|
| Weather | 1 | 2015 | 10 | 0.120 |
Why?
|
| DNA, Single-Stranded | 1 | 2015 | 39 | 0.120 |
Why?
|
| Catalysis | 1 | 2016 | 191 | 0.120 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 17 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2017 | 411 | 0.120 |
Why?
|
| Dysmenorrhea | 1 | 2015 | 3 | 0.120 |
Why?
|
| Fluorescein | 1 | 2015 | 18 | 0.120 |
Why?
|
| Birds | 1 | 2016 | 93 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 67 | 0.110 |
Why?
|
| Brugada Syndrome | 1 | 2014 | 2 | 0.110 |
Why?
|
| Biofilms | 1 | 2016 | 178 | 0.110 |
Why?
|
| Serotonin | 1 | 2015 | 125 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 68 | 0.110 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 56 | 0.110 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2014 | 25 | 0.110 |
Why?
|
| Rats | 3 | 2017 | 3701 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 456 | 0.110 |
Why?
|
| Analgesics | 1 | 2015 | 55 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 649 | 0.110 |
Why?
|
| Dengue Virus | 1 | 2015 | 89 | 0.110 |
Why?
|
| Young Adult | 6 | 2025 | 4936 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2025 | 733 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2015 | 99 | 0.110 |
Why?
|
| Infant, Newborn | 2 | 2024 | 960 | 0.110 |
Why?
|
| Intensive Care Units | 1 | 2014 | 71 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2014 | 42 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 254 | 0.110 |
Why?
|
| Dengue | 1 | 2015 | 100 | 0.110 |
Why?
|
| Patient Discharge | 1 | 2014 | 131 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 1 | 2014 | 156 | 0.100 |
Why?
|
| RNA, Viral | 1 | 2015 | 317 | 0.100 |
Why?
|
| Tourniquets | 1 | 2012 | 1 | 0.100 |
Why?
|
| Soft Tissue Injuries | 1 | 2012 | 1 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2015 | 176 | 0.100 |
Why?
|
| Linear Models | 2 | 2012 | 311 | 0.100 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2012 | 14 | 0.100 |
Why?
|
| Bacteria | 1 | 2016 | 285 | 0.100 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 15 | 0.100 |
Why?
|
| Research Design | 1 | 2015 | 370 | 0.100 |
Why?
|
| Base Sequence | 1 | 2014 | 997 | 0.090 |
Why?
|
| Uganda | 2 | 2025 | 22 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 680 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 580 | 0.090 |
Why?
|
| Pain | 1 | 2015 | 283 | 0.090 |
Why?
|
| Hepatitis B | 1 | 2011 | 41 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2011 | 15 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2023 | 366 | 0.090 |
Why?
|
| Musculoskeletal System | 1 | 2011 | 9 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1559 | 0.090 |
Why?
|
| Clavicle | 1 | 2010 | 2 | 0.090 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2010 | 4 | 0.090 |
Why?
|
| Counseling | 2 | 2025 | 134 | 0.090 |
Why?
|
| Knee | 1 | 2010 | 8 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 2010 | 19 | 0.090 |
Why?
|
| Femoral Neck Fractures | 1 | 2010 | 1 | 0.080 |
Why?
|
| Protons | 1 | 2011 | 94 | 0.080 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2010 | 6 | 0.080 |
Why?
|
| Temperature | 1 | 2011 | 314 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2010 | 61 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2010 | 62 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 300 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2010 | 56 | 0.080 |
Why?
|
| Depression | 1 | 2017 | 837 | 0.080 |
Why?
|
| Ethidium | 1 | 2009 | 7 | 0.080 |
Why?
|
| NADP | 1 | 2009 | 37 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 246 | 0.080 |
Why?
|
| Fluorescence | 1 | 2009 | 113 | 0.070 |
Why?
|
| Surface Properties | 2 | 2007 | 157 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2010 | 574 | 0.070 |
Why?
|
| Premature Birth | 1 | 2010 | 94 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 438 | 0.070 |
Why?
|
| Dental Bonding | 1 | 2007 | 1 | 0.070 |
Why?
|
| Inlays | 1 | 2007 | 1 | 0.070 |
Why?
|
| Resin Cements | 1 | 2007 | 1 | 0.070 |
Why?
|
| Dentin | 1 | 2007 | 3 | 0.070 |
Why?
|
| Composite Resins | 1 | 2007 | 5 | 0.070 |
Why?
|
| United States | 2 | 2025 | 5072 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2016 | 158 | 0.060 |
Why?
|
| Silicon Compounds | 1 | 2006 | 7 | 0.060 |
Why?
|
| Risk Factors | 1 | 2014 | 3942 | 0.060 |
Why?
|
| Glycerophospholipids | 1 | 2025 | 4 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2005 | 63 | 0.060 |
Why?
|
| Scattering, Radiation | 1 | 2005 | 43 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2024 | 1516 | 0.060 |
Why?
|
| Family Characteristics | 1 | 2025 | 124 | 0.060 |
Why?
|
| Pregnancy | 1 | 2010 | 1737 | 0.060 |
Why?
|
| Taiwan | 1 | 2024 | 21 | 0.050 |
Why?
|
| Ulnar Nerve | 1 | 2023 | 1 | 0.050 |
Why?
|
| Humerus | 1 | 2023 | 4 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2005 | 93 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2024 | 224 | 0.050 |
Why?
|
| Age Distribution | 1 | 2024 | 249 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2024 | 95 | 0.050 |
Why?
|
| Bone Plates | 1 | 2023 | 4 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2023 | 132 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2003 | 42 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2023 | 46 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 64 | 0.050 |
Why?
|
| Length of Stay | 1 | 2024 | 231 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 273 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2003 | 58 | 0.050 |
Why?
|
| Recurrence | 1 | 2022 | 149 | 0.050 |
Why?
|
| Registries | 1 | 2024 | 431 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 2803 | 0.040 |
Why?
|
| Heart | 1 | 2003 | 181 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 150 | 0.040 |
Why?
|
| Comorbidity | 1 | 2024 | 725 | 0.040 |
Why?
|
| Incidence | 1 | 2024 | 1054 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 121 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1143 | 0.040 |
Why?
|
| Hospitalization | 1 | 2024 | 482 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 850 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 1597 | 0.040 |
Why?
|
| Glottis | 1 | 2018 | 2 | 0.040 |
Why?
|
| Vocal Cord Paralysis | 1 | 2018 | 2 | 0.040 |
Why?
|
| Voice Quality | 1 | 2018 | 5 | 0.040 |
Why?
|
| Laryngeal Neoplasms | 1 | 2018 | 13 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2020 | 206 | 0.040 |
Why?
|
| Demography | 1 | 2018 | 195 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1058 | 0.030 |
Why?
|
| Spinal Nerves | 1 | 2017 | 5 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2017 | 47 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2017 | 23 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 309 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 191 | 0.030 |
Why?
|
| Food Contamination | 1 | 2016 | 55 | 0.030 |
Why?
|
| Biomass | 1 | 2016 | 66 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1020 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 141 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 114 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 207 | 0.030 |
Why?
|
| Urination | 1 | 2015 | 3 | 0.030 |
Why?
|
| Urodynamics | 1 | 2015 | 5 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2016 | 132 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 708 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 2017 | 196 | 0.030 |
Why?
|
| Peru | 1 | 2015 | 40 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 483 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2016 | 168 | 0.030 |
Why?
|
| Respiratory System | 1 | 2015 | 31 | 0.030 |
Why?
|
| Electromyography | 1 | 2015 | 69 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1139 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1008 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 452 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 151 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2015 | 154 | 0.030 |
Why?
|
| Rural Population | 1 | 2017 | 352 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 534 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 796 | 0.030 |
Why?
|
| Sleep | 1 | 2015 | 179 | 0.030 |
Why?
|
| Hemostasis, Surgical | 1 | 2012 | 2 | 0.030 |
Why?
|
| Hematocrit | 1 | 2012 | 25 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2012 | 112 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 1169 | 0.020 |
Why?
|
| Smoking | 1 | 2018 | 1019 | 0.020 |
Why?
|
| Shoulder Joint | 1 | 2010 | 4 | 0.020 |
Why?
|
| Patella | 1 | 2010 | 1 | 0.020 |
Why?
|
| Automation | 1 | 2010 | 23 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2010 | 37 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1848 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2010 | 48 | 0.020 |
Why?
|
| Radiography | 1 | 2010 | 72 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 107 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 638 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 170 | 0.020 |
Why?
|
| Dental Cavity Preparation | 1 | 2007 | 1 | 0.020 |
Why?
|
| Dentin Permeability | 1 | 2007 | 1 | 0.020 |
Why?
|
| Acid Etching, Dental | 1 | 2007 | 2 | 0.020 |
Why?
|
| Dental Stress Analysis | 1 | 2007 | 5 | 0.020 |
Why?
|
| Lasers, Solid-State | 1 | 2007 | 12 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2007 | 27 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 1051 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2003 | 10 | 0.010 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2003 | 9 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 2003 | 9 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 670 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2003 | 88 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 292 | 0.010 |
Why?
|
| Triglycerides | 1 | 2003 | 146 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 101 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2003 | 92 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 230 | 0.010 |
Why?
|
| Action Potentials | 1 | 2003 | 246 | 0.010 |
Why?
|